Daniel F Nogales

Title: **Innovations by Daniel F. Nogales: Transforming Neuronal Treatments**

Introduction

Daniel F. Nogales, an inventive mind hailing from Nampa, ID, has made significant contributions to the field of medicinal chemistry through his patent work. As a distinguished inventor, he holds two patents that are advancing the understanding and treatment of various neurological conditions. His innovative approach focuses on azepine compounds, which have promising applications in treating neuronal loss and neurodegenerative diseases.

Latest Patents

Daniel’s latest patents involve the synthesis and application of azepine compounds. Disclosed are methods of preparing azepines through a multistep synthesis that includes a Diels-Alder reaction. These methods provide innovative solutions for treating or preventing neuronal loss associated with stroke, ischemia, CNS trauma, hypoglycemia, and surgery. Additionally, these patents address neurodegenerative diseases, including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, and Down's syndrome. The formulations aim to mitigate the adverse effects of hyperactivity in excitatory amino acids, as well as treat anxiety, chronic pain, convulsions, and opiate tolerance by administering an azepine with high binding affinity to the NMDA glycine site.

Career Highlights

Throughout his career, Daniel F. Nogales has collaborated with various esteemed organizations. Among these, he has worked with the State of Oregon and Acea Pharmaceuticals, Inc., contributing his expertise to enhance pharmaceutical innovations and research in the area of neuronal health.

Collaborations

Daniel has worked alongside notable colleagues, including John F. Keana and Anthony P. Guzikowski. These collaborations have further bolstered innovation, leading to significant advancements in therapeutic strategies in the field of neurology.

Conclusion

Daniel F. Nogales stands out as a key inventor whose work in azepine compounds is paving the way for new treatment avenues in neurological care. His innovative contributions hold the potential to improve the quality of life for individuals affected by various cognitive disorders and neurodegenerative diseases. With a solid foundation in both research and practical application, Daniel’s ongoing efforts in medicinal chemistry will undoubtedly continue to inspire advancements in this vital field.